Investor Relations

Investors Overview

Press Releases

Apr 22, 2015
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release first quarter 2015 financial and operating results before the market opens on Wednesday, May 6, 2015. Todd M. Pope, President & Chief Executive Officer and Joseph P. Slattery, Executive Vic...
Apr 16, 2015
SurgiBotTM system FDA 510(k) filing on track for mid-2015 submission RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive s...

Events & Presentations

May 6, 2015 at 8:30 AM ET

NYSE: TRXC

3.72
0.18 (+4.94%)
12:45 PM ET on Apr 27, 2015
Open: 3.54
High: 3.74
Volume: 140,400
Close: 3.54
Low: 3.48
Delayed at least 20 minutes.

SEC Filings

Date Filed Filing Description View
Apr 21, 2015 8-K current report HTML PDF XLS
Apr 16, 2015 8-K current report HTML PDF XLS
Apr 7, 2015 DEF 14A definitive proxy statement HTML PDF XLS

Corporate Governance

Title View
Audit Committee Charter
PDF
38.0 KB
Compensation Committee Charter
PDF
24.2 KB
Corporate Governance and Nominating Committee Charter
PDF
29.0 KB
Code of Business Conduct and Ethics
PDF
74.1 KB

Information Statement

Feb 21, 2014